Related Experiment Video
Updated: Apr 29, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention
Insights
Serum uric acid levels do not predict periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention. This large study found no association between uric acid and myocardial infarction risk after the procedure.
Area of Science:
- Cardiology
- Biomarkers
- Interventional Cardiology
Background:
- Periprocedural myocardial infarction (MI) is a complication of percutaneous coronary intervention (PCI).
- The predictive role of biomarkers for periprocedural MI remains unclear.
- Serum uric acid is linked to inflammation, thrombosis, and adverse outcomes post-PCI.
Purpose of the Study:
- To evaluate the association between serum uric acid levels and periprocedural myocardial infarction in patients undergoing PCI.
- To determine if uric acid can serve as a predictive biomarker for MI following PCI.
Main Methods:
- A study of 1272 consecutive patients undergoing PCI.
- Measurement of myonecrosis biomarkers (troponin I, creatine kinase-MB) 8-48 hours post-PCI.
- Definition of periprocedural myonecrosis and myocardial infarction based on biomarker thresholds.
Main Results:
- Serum uric acid levels were associated with various clinical and laboratory parameters, including age, comorbidities, and renal function.
- Serum uric acid was inversely related to lesion complexity and coronary thrombus.
- No significant association was found between serum uric acid levels and the risk of periprocedural myocardial infarction or myonecrosis.
Conclusions:
- This study is the first large-scale investigation to demonstrate that serum uric acid is not associated with an increased risk of periprocedural myocardial infarction.
- Findings suggest serum uric acid is not a reliable predictor of periprocedural MI in patients undergoing PCI.
Background:
Periprocedural myocardial infarction still occurs in patients undergoing percutaneous coronary intervention. However, very little is known about the role of biomarkers possibly predicting this complication. Serum uric acid has been associated with enhanced inflammatory status, higher thrombotic risk and poorer outcome after percutaneous coronary intervention. We therefore, evaluated the association between uric acid levels and periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
Methods:
We evaluated 1272 consecutive patients undergoing percutaneous coronary intervention. We measured myonecrosis biomarkers at intervals from 8 to 48 h after percutaneous coronary intervention. Periprocedural myonecrosis was defined as a troponin I increase by 3 times the upper limit normal (ULN) or by 50% of an elevated baseline value and periprocedural myocardial infarction as creatine kinase-Myocardial Band increase by 3 times the ULN or 50% of baseline.
Results:
Patients were divided according to tertile values of uric acid (< 5.40, ≥ 6.70 mg/dL). Serum uric acid was related to age, male gender, hypertension, smoking, renal failure (p < 0.001), previous coronary artery bypass grafts (p = 0.05), therapy with ACE inhibitors (p = 0.001) and diuretics (p < 0.001), glycaemia (p = 0.001), creatinine (p < 0.001), haemoglobin (p = 0.002) and white blood cells (p = 0.02). Serum uric acid was inversely related to type C lesions (p = 0.03) and coronary thrombus (p = 0.02). SUA did not affect the risk of periprocedural myocardial infarction (p = 0.29; adjusted odds ratio = 1.11[0.93-1.32], p = 0.26) or periprocedural myonecrosis (p = 0.97; adjusted odds ratio = 0.99[0.86-1.14], p = 0.89). Results were confirmed at subgroup analyses of higher-risk subsets of patients.
Conclusion:
This is the first large study showing that serum uric acid is not associated with an increase in the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary revascularization.
More Related Videos
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome IV: Interprofessional Care
Cardiac Catheterization II: Right Heart Catheterization
Peripheral Artery Disease III: Interprofessional Care
Pericarditis I: Introduction
Cardiac Catheterization IV: Nursing Management